7m��Ƶ

Keep updated with our publications and activities by following Dr. Beeton on Twitter @christinebeeton.

July

• Christine Beeton presented a seminar on using venom toxins to treat autoimmune diseases to students of the SMART Summer Research Program.

June

*Christine Beeton was a keynote speaker at the Nanion meeting in Boston.

May

• The Beeton and Hyser labs had lunch at Benjy’s to celebrate Brayden Chamberlain’s acceptance into Medical School, to say goodbye, and to wish him the very best in his studies and his career.
• Mark R. Tanner delivered the graduate address at the College’s Commencement ceremony as Representative for the Graduate School of Biomedical Sciences.
• Carol Garcia, from Augustana College, joined the Beeton Lab as part of the SMART Summer Research Program.
• Mark R. Tanner received an award for his poster presentation during the annual joint Immunology retreat between the Graduate Program in Immunology at 7m��Ƶ, the Biology of Inflammation Center, and the Baylor Scott & White Institute for Immunology Research.
• Christine Beeton and Mark R. Tanner attended the annual joint Immunology retreat between the Graduate Program in Immunology at 7m��Ƶ, the Biology of Inflammation Center, and the Baylor Scott & White Institute for Immunology Research. They presented a talk and a poster, respectively.
• Christine Beeton received one of five Clark Faculty Service Awards for exemplary service contributions to 7m��Ƶ.
• Christine Beeton was invited to deliver the weekly seminar of the Center for Metagenomics and Microbiome Research at 7m��Ƶ.
• Mark R. Tanner received the 2018 Lehmann Outstanding Student award from the Graduate School in Biomedical Sciences at 7m��Ƶ.

March

• Only two weeks after its publication, our article “Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis” in The Journal of Pharmacology and Experimental Therapeutics is already in the top 5 percent of all research outputs scored by Altmetric.
• Christine Beeton attended the retreat of the Center for Metagenomics and Microbiome Research and partnered with Dr. Dilling, director of the Baylor Licensing Group, to lead a discussion around the commercialization of research findings.

February

• Press release “Scorpion venom component may treat rheumatoid arthritis” about our latest publication.
• Christine Beeton attended the retreat of the Department of Molecular Physiology and Biophysics.

January

• Members of the Beeton Lab had lunch at Third Coast.
• Mark R. Tanner defended his Ph.D. thesis “Potassium channels as targets for rheumatoid arthritis”.

July

• Members of the Beeton Lab had lunch at Third Coast prior to Clarissa Palacios’ departure for The University of Texas in El Paso.
• Our work on targeting KCa1.1 (BK) channels for the treatment of rheumatoid arthritis was highlighted in the blog of the Arthritis Foundation ().
• The team at Kineta published the results from the phase 1b clinical trial of dalazatide (formerly ShK-186) in patients with psoriasis: . ShK-186 was developed through NIH- and foundation-funded research by Drs. Beeton, Chandy, and Pennington and their collaborators worldwide. Dalazatide is the first specific Kv1.3 blocker to advance into clinic.
• Annual lab outing to Brazos Bend State Park to see alligators, banana spiders, birds, and fireflies followed by lunch at Christine Beeton’s house.

May

• Clarissa Palacios, from The University of Texas in El Paso, joined the Beeton Lab as part of the and the SMART Summer Research Programs.

April

• Christine Beeton attended the joint Immunology Retreat between the Graduate Program in Immunology at 7m��Ƶ, the Biology of Inflammation Center, the Center for Human Immunobiology and the Baylor Scott & White Institute for Immunology Research.

March

• Christine Beeton was invited to talk about our work on PEG-HCCs in autoimmune diseases to the Sugar Land Multiple Sclerosis Self-Help Group.
• Members of the Beeton Lab spoke with Emily Akin from Fox 26 Houston News about our work with Dalazatide (ShK-186) for the treatment of autoimmune diseases.

*Christine Beeton and Mark Tanner attended the retreat of the Graduate Program in Translational Biology and Molecular Medicine. Mark’s abstract was selected for an oral presentation.

February

*Christine Beeton and Mark Tanner attended the retreat of the Department of Molecular Physiology and Biophysics. They presented a talk and a poster, respectively.

January

*Members of the Beeton lab had lunch at Miller’s Café.

December

• Redwan Huq defended his Ph.D. thesis “Antioxidant carbon nanoparticles for treating T lymphocyte-mediated autoimmune diseases”.
• Christine Beeton was invited to present our work on targeting potassium channels for the treatment of rheumatoid arthritis at the 23^rd meeting of the French Society of Toxinology in Paris, France.

November

• Mark Tanner received a travel award to attend and present his work at the annual meeting of the American College of Rheumatology and the Association of Rheumatology health Professionals, in Washington, DC.

October

• Rajeev Tajhya defended his Ph.D. thesis “Potassium channels in myotonic dystrophy type 1”.
• Christine Beeton gave a Biology of Inflammation and the Immunology seminar “Targeting Kv1.3 channels in autoimmunity – From the sea anemone venom to the clinic”.

September

• Christine Beeton spoke live on SiriusXM channel 110 Doctor Radio about PEG-HCCs as a tattoo therapy for autoimmune diseases.
• Mark Tanner was selected by the Interdepartmental Graduate Program in Translational Biology and Molecular Medicine as their nominee for a Debra K. Martin Award.
• Christine Beeton spoke about PEG-HCCs as a tattoo therapy for autoimmune diseases for Fox 5 NY.
• Press release “Tattoo therapy could ease chronic disease; skin-embedded nanoparticles may help control autoimmune diseases” about our latest publication. /news/molecular-physiology-and-biophysics/nanoparticle-therapy-for-autoimmune-disease

August

• Christine Beeton gave a seminar “Venom-derived peptides for the treatment of rheumatoid arthritis” in the Division of Chemistry & Structural Biology of the University of Queensland, St Lucia, Australia.
• Christine Beeton attended the International Congress of Immunology in Melbourne, Australia (http://ici2016.org). She gave two talks about our work on KCa1.1 channels in rheumatoid arthritis and on PEG-HCCs in T lymphocyte immunomodulation.
• Christine Beeton gave a seminar “Venom-derived peptides for the treatment of rheumatoid arthritis” in the Department of Medicinal Chemistry of the Monash Institute of Pharmaceutical Sciences, Melbourne, Australia.

July

• Members of the Beeton Lab had lunch at Coppa Osteria prior to Kathia Rodarte’s departure for The University of Texas in El Paso.

June

• *Christine Beeton was invited to present our work on targeting potassium channels in rheumatoid arthritis during the seminar series of the Center for Translational Research on Inflammatory Diseases at the Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.

May

• Kathia Rodarte, from The University of Texas in El Paso, joined the Beeton Lab as part of the and the SMART Summer Research Programs.
• Redwan Huq presented his work in the Molecular Physiology and Biophysics Seminar Series at 7m��Ƶ.
• Mark R. Tanner was awarded an F31 Predoctoral Individual National Research Service Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for his work on potassium channels in rheumatoid arthritis.

April

• Christine Beeton was invited to present work on Kv1.3 blockers as immunomodulators to treat autoimmune diseases in the Therapeutic Stream “Biologics for Autoimmune Diseases” during the Protein and Antibody Engineering Summit in Boston, MA.
• Christine Beeton attended the joint 7m��Ƶ and Baylor Institute for Immunology Research retreat in Lake Conroe and presented our work on antioxidant nanomaterials for T lymphocyte immunomodulation.

March

• Christine Beeton participated with Drs. Catic and Pereira in a panel discussion “Academic Interviews: How to Prepare and What You Need to Know Before the Tenure Clock Starts Running” organized by Derek Haseltine, director of the 7m��Ƶ Career Development Center.

February

• Christine Beeton and Redwan Huq gave interviews for Team Launch. Team Launch provides innovative, interdisciplinary learning opportunities that will prepare students for careers in team-based science and healthcare.
• Mark R. Tanner presented his work in the Immunology Seminar Series at 7m��Ƶ.

January 2016

• Redwan Huq became the Founding President of the Consulting Club of the Texas Medical Center.